This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Global Radiation Therapy Equipment Industry

7. CANCER THERAPY - EPIDEMIOLOGY II-42Four Progressive Stages of Cancer II-42Types of Cancer II-42Breast Cancer II-43Treatment Options II-43Major Developments in the Treatment Area of Breast Cancer II-43Colorectal Cancer II-44Prostate Cancer II-44Pancreatic Cancer II-45Cervical Cancer II-45Esophageal Cancer II-45Lung Cancer II-45Treatment Options Available II-46Technological Developments II-46Cures II-46Enhanced Therapies II-46Prevention and Public Awareness II-46Better Screening and Earlier Detection II-46Other Emerging Therapies II-46

8. RADIOTHERAPY II-48Comprehensive Review of Radiation Therapy II-48Radiation Therapy - A Panacea for all Cancer Diseases II-49Composition of Radiation Therapy Treatment Team II-49Types of Radiation Therapy II-49Brachytherapy II-49More About Brachytherapy II-50Technical Scope of Brachytherapy II-50Radiation Therapy for Treating Oral Cancer II-50Other Forms of Radiation Therapy II-51Photoradiation Therapy (PRT) II-51Photodynamic Therapy (PDT) II-51Cost of Radiation Therapy II-51Limitations of Conventional Radiation Therapy Techniques II-52

9. CANCER TREATMENT - A COST ANALYSIS II-53Demographics II-53Matrix of Death II-53Improved Therapies II-53Increase in Out-Patient Care II-53Hospital Market Under Pressure II-53Medicare and Medicaid Reimbursement II-54

10. MAJOR DEVELOPMENTS II-55New Generation of Systems Under Development II-553-D Conformal Radiation Therapy: A New Technology II-55IMRT: Gains Significance II-55Types of IMRT II-56Dynamic Multi Leaf Collimator IMRT II-56Segmental Multi Leaf Collimator IMRT II-56Image-Guided IMRT II-56Mobetron™ - Radiation Therapy on the Wheels II-56Radiation Therapy: An Effective Way to Reduce Restenosis II-56High Dose Radiation Treatment Found to Reduce Side Effects inProstate Cancer Treatment II-56Four-Dimensional CT Scanning II-57Convergence of PET and CT Images for Treatment Planning II-57World's First 3-D Image-Guided Radiation Therapy System fromElekta II-57Stereotactic Radiosurgery - An Overview II-57Gamma Knife II-57Precision Therapy II-58CyberKnife II-58TomoTherapy II-58

11. PRODUCT INNOVATIONS/INTRODUCTIONS II-59MIM to Launch Co-branded Version of Mobile MIM 3.0 II-59MIM Launches Upgraded Mobile MIM 3.0 II-59Shimadzu and Hokkaido University Jointly Develop Cancer Cell-Tracking System II-59IZI Medical Launches Innovative Positioning Devices forRadiation Therapy II-59Elekta Introduces New XiO® Treatment Planning System and FocalContouring System II-60Elekta Launches New Monaco® 3.0 DCA Treatment Planning System II-60KAERI Develops Native High-Power Proton Accelerator II-60E United Group to Introduce Radiation Equipment in Taiwan II-61

12. PRODUCT LAUNCHES IN RECENT PAST - A PERSPECTIVE BUILDER II-62TomoTherapy Forges Alliance with NELCO to Offer RadiationShielding Solution II-62Integra Unveils Upgraded Software for Radiotherapy Treatment II-62Varian Medical Systems Unveils TrueBeam™ II-63Elekta Unveils Monaco Version 2.03 II-63Acceletronics Introduces Theraview KV Imaging IGRT System II-63Nucletron Introduces Oncentra® Simulation 2.3 II-64Siemens Healthcare Rolls Out ARTISTE Linear Accelerator II-64MDS Nordion Introduces Enhanced TheraSphere® AdministrationSystem II-64VMS Showcases Recent Treatment Solution for Energy-SavingRadiation Therapy II-65VMS Introduces New Surgical Device for Inoperable Lung CancerCases II-65

3 of 4

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,959.44 +154.64 0.87%
S&P 500 2,078.54 +7.89 0.38%
NASDAQ 4,781.4240 +16.0440 0.34%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs